“Safety and Tolerability of Tirbanibulin 1% Treatment of Actinic Keratosis on Face and Scalp in Routine Clinical Practice Across the U.S. (PROAK Study)”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s263. Accessed April 17, 2026. https://skin.dermsquared.com/skin/article/view/2338.